Diminished anti-retroviral therapy (ART) exposure and improved virological and immune outcomes with therapeutic vaccination after ART intensification, GM-CSF, and hydroxyurea in chronic HIV disease: a 5½-year pilot trial (CTN 140 study)

E Toma (Speaker), M Loignon (Speaker), Sindhu, S. (Speaker), A Thorne (Speaker), D Zarowny (Speaker), NF Bernard (Speaker), L-G Labrecque (Speaker), C Tremblay (Speaker), L Cyr (Speaker), M-P Cordeau (Speaker), K Huang (Speaker), R Beaulieu (Speaker), José Menezes (Invited speaker)